Frank Harris
Family Medicine · White House, TNNPI 1891144572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $943 and has fallen 84.1% since, to $150 in 2025.
Across 138 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$264
- Novo Nordisk$256
- AbbVie$198
- Sanofi-aventis U.S. LLC$189
- Bayer$172
- Pfizer$148
- plus $1K from 28 others
What the payments were for
- Speaking & faculty fees$1506%
- Food & beverage$2,34694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 10 | $264 |
| Novo Nordisk | 18 | $256 |
| AbbVie | 18 | $198 |
| Sanofi-aventis U.S. LLC | 3 | $189 |
| Bayer | 5 | $172 |
| Pfizer | 10 | $148 |
| Amgen | 10 | $148 |
| Boehringer Ingelheim | 10 | $148 |
| Astellas Pharma US Inc | 1 | $108 |
| Lilly USA, LLC | 7 | $98 |
| AstraZeneca | 6 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Merck | 4 | $58 |
| Novartis | 4 | $53 |
| Amarin Pharma, Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Insulet Corporation | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $35 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Eisai Inc. | 2 | $32 |
| ZOLL Respicardia, Inc. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $21 |
| Harmony Biosciences LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Medicure Pharma Inc. | 1 | $13 |
| Vistapharm, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,496 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 23 | $160 |
Paid to pharmacies, not to this prescriber.
Other family medicine in White House
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.